A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077) (clinicaltrials.gov) - Jan 23, 2026 - P1 | N=40 | Recruiting | Sponsor: Merck Sharp & Dohme LLC | Initiation date: Nov 2025 ➔ Feb 2026
Trial initiation date • Cytomegalovirus Infection • Pediatrics • Transplantation
|